Netherlands · Biotechnology startup
Netherlands · New Amsterdam Pharma
New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.
Funding reportedLast round: Post ipo equity
What company datasets say New Amsterdam Pharma raised
Funding, as reported
Reported in all786.3Min the source's currency
Rounds5
Last roundPost ipo equity
Last round dateFeb 2024
Investors listed22
On 2 portfolio pages
Investors who name them
Each firm lists New Amsterdam Pharma on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biotechnology in Netherlands
Startups like it
Is this your company?
Add your raise, your deck and your story, and put New Amsterdam Pharma in front of investors. Or tell us what we have wrong.